NCT00212108: A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 |
|
|
| Completed | 1/2 | 22 | RoW | celecoxib, gefitinib, ZD1839 (Iressa™) | National University Hospital, Singapore, National Healthcare Group, Singapore | Nasopharyngeal Carcinoma | 03/07 | 01/09 | | |
